THYROCARE TECHNOLOGIES Financial Statement Analysis
|
||
|
The Revenues of THYROCARE TECHNOLOGIES have increased by 19.05% YoY .
The Earnings Per Share (EPS) of THYROCARE TECHNOLOGIES has decreased by -62.59 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
THYROCARE TECHNOLOGIES Last 5 Annual Financial Results
[BOM: 539871|NSE : THYROCARE]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Operating Income | ₹589 Cr | ₹495 Cr | ₹434 Cr | ₹403 Cr | ₹356 Cr |
| Expenses | ₹353 Cr | ₹323 Cr | ₹261 Cr | ₹249 Cr | ₹212 Cr |
| Operating Profit (Excl OI) | ₹236 Cr | ₹171 Cr | ₹174 Cr | ₹154 Cr | ₹145 Cr |
| Other Income | ₹29 Cr | ₹12 Cr | ₹6.67 Cr | ₹10 Cr | ₹23 Cr |
| Interest | ₹3.21 Cr | ₹0.87 Cr | ₹1.85 Cr | ₹0.61 Cr | ₹0.44 Cr |
| Depreciation | ₹34 Cr | ₹30 Cr | ₹32 Cr | ₹26 Cr | ₹20 Cr |
| Profit Before Tax | ₹228 Cr | ₹152 Cr | ₹140 Cr | ₹138 Cr | ₹145 Cr |
| Profit After Tax | ₹176 Cr | ₹113 Cr | ₹88 Cr | ₹85 Cr | ₹93 Cr |
| Consolidated Net Profit | ₹176 Cr | ₹112 Cr | ₹89 Cr | ₹85 Cr | ₹93 Cr |
| Earnings Per Share (Rs) | ₹12.45 | ₹33.28 | ₹21.14 | ₹16.75 | ₹16.15 |
| PAT Margin (%) | 12.22 | 29.91 | 22.88 | 20.24 | 20.99 |
| ROE(%) | 12.23 | 37.18 | 28.75 | 22.13 | 19.41 |
| ROCE(%) | 17.61 | 48.42 | 38.51 | 35.14 | 31.36 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Key Financials |
||
| Market Cap | : | ₹ 3,496.1 Cr |
| Revenue (TTM) | : | ₹ 553.5 Cr |
| Net Profit(TTM) | : | ₹ 63.9 Cr |
| EPS (TTM) | : | ₹ 12.1 |
| P/E (TTM) | : | 54.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| THYROCARE TECHNOLOGIES | -6.6% | -6.1% | 34.2% |
| APOLLO HOSPITALS ENTERPRISE | 3.4% | -6.6% | 49% |
| MAX HEALTHCARE INSTITUTE | 5.7% | -8.7% | 59.1% |
| GLOBAL HEALTH | 6.7% | -13.1% | 164.4% |
| FORTIS HEALTHCARE | 2.6% | -6.4% | 59.4% |
| NARAYANA HRUDAYALAYA | 2% | -9.6% | 59.5% |
| ASTER DM HEALTHCARE | 1.9% | -6.1% | 86.2% |
| DR LAL PATHLABS | 12.9% | -7.3% | 19.6% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 3.3% | -8.3% | 51.4% |
THYROCARE TECHNOLOGIES Revenues
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | 19.05 % |
| 5 Yr CAGR | 13.38 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹589 Cr | 19.05 | |
| Mar2022 | ₹495 Cr | 13.90 | |
| Mar2021 | ₹434 Cr | 7.78 | |
| Mar2020 | ₹403 Cr | 13.08 | |
| Mar2019 | ₹356 Cr | - | |
THYROCARE TECHNOLOGIES Operating Profit
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | 37.64 % |
| 5 Yr CAGR | 12.99 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹236 Cr | 37.64 | |
| Mar2022 | ₹171 Cr | -1.33 | |
| Mar2021 | ₹174 Cr | 12.59 | |
| Mar2020 | ₹154 Cr | 6.59 | |
| Mar2019 | ₹145 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 15.63 % |
| 5 Yr CAGR | -0.35 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 40.03% | 15.63 | |
| Mar2022 | 34.62% | -13.39 | |
| Mar2021 | 39.97% | 4.47 | |
| Mar2020 | 38.26% | -5.74 | |
| Mar2019 | 40.59% | - | |
THYROCARE TECHNOLOGIES Profit After Tax
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | 57.53 % |
| 5 Yr CAGR | 17.16 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹176 Cr | 57.53 | |
| Mar2022 | ₹112 Cr | 26.25 | |
| Mar2021 | ₹89 Cr | 3.84 | |
| Mar2020 | ₹85 Cr | -8.77 | |
| Mar2019 | ₹93 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -59.14 % |
| 5 Yr CAGR | -12.65 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 12.22 % | -59.14 | |
| Mar2022 | 29.91 % | 30.73 | |
| Mar2021 | 22.88 % | 13.04 | |
| Mar2020 | 20.24 % | -3.57 | |
| Mar2019 | 20.99 % | - | |
THYROCARE TECHNOLOGIES Earnings Per Share (EPS)
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | -62.59 % |
| 5 Yr CAGR | -6.30 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹12 | -62.59 | |
| Mar2022 | ₹33 | 57.43 | |
| Mar2021 | ₹21 | 26.21 | |
| Mar2020 | ₹17 | 3.72 | |
| Mar2019 | ₹16 | - | |
THYROCARE TECHNOLOGIES Return on Capital Employed (ROCE)
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | -63.63 % |
| 5 Yr CAGR | -13.43 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 17.61% | -63.63 | |
| Mar2022 | 48.42% | 25.73 | |
| Mar2021 | 38.51% | 9.59 | |
| Mar2020 | 35.14% | 12.05 | |
| Mar2019 | 31.36% | - | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Current Share Price | : | ₹659.7 |
| Current MarketCap | : | ₹ 3,496.1 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -6.6% |
-6.1% |
34.2% |
| SENSEX | 1.3% |
2.6% |
24% |
THYROCARE TECHNOLOGIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
| S&P BSE HEALTHCARE | -0.2% | 3.7% | 52.1% |
No NSE index found
You may also like the below Video Courses
FAQ about THYROCARE TECHNOLOGIES Financials
How the annual revenues of THYROCARE TECHNOLOGIES have changed ?
The Revenues of THYROCARE TECHNOLOGIES have increased by 19.05% YoY .
How the Earnings per Share (EPS) of THYROCARE TECHNOLOGIES have changed?
The Earnings Per Share (EPS) of THYROCARE TECHNOLOGIES has decreased by -62.59 % YoY .
Check out Intrinsic Value of Peers of THYROCARE TECHNOLOGIES
Compare Stock Analytics of Peers of THYROCARE TECHNOLOGIES
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs GLOBAL HEALTH LTD
FORTIS HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs GLOBAL HEALTH LTD
FORTIS HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
